Center-Authored Papers

Filters: Author is Mauro, Michael J  [Clear All Filters]
2012
Cortes J, Radich J, Mauro MJ.  2012.  Clinical roundtable monograph: Emerging treatment options for TKI-resistant chronic myelogenous leukemia.. Clinical advances in hematology & oncology : H&O. 10(10 Suppl 19):1-16. Abstract
2013
Radich JP, Mauro MJ.  2013.  Sequential therapy in chronic myelogenous leukemia: general discussion.. Clinical advances in hematology & oncology : H&O. 11(11 Suppl 17):13-4.
2014
Radich JP, Shah NP, Mauro MJ.  2014.  Integrating current treatment options for TKI-resistant chronic myeloid leukemia.. Clinical advances in hematology & oncology : H&O. 12(7 Suppl 13):3-17,1. Abstract
2017
Radich JP, Mauro MJ.  2017.  Tyrosine Kinase Inhibitor Treatment for Newly Diagnosed Chronic Myeloid Leukemia.. Hematology/oncology clinics of North America. 31(4):577-587. Abstract
Carpenter PA, Johnston L, Fernandez HF, Radich JP, Mauro MJ, Flowers MED, Martin PJ, Gooley TA.  2017.  Post-transplant feasibility study of nilotinib prophylaxis for high-risk Philadelphia chromosome positive leukemia.. Blood.